Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
In BriefThis Month in JNM

This Month in JNM

Journal of Nuclear Medicine November 2015, 56 (11) 8A;
  • Article
  • Info & Metrics
  • PDF
Loading

Nanoparticles for cardiovascular imaging: Stendahl and Sinusas provide the second of 2 overviews, here describing current examples of radiolabeled nanoparticulate probes for PET and SPECT and their utility in a range of preclinical cardiac applications.

Page 1637

Tumor texture analysis and PET: Buvat and colleagues offer perspectives on current image analysis approaches and areas for needed advancement in PET characterization of tumor heterogeneity.

Page 1642

Innervation–MBF and 11C-HED PET: Dilsizian and Eckelman look at challenges associated with using a single radioisotope in PET assessment of both myocardial blood flow and innervation and preview an article on this topic in this issue of JNM.

Page 1645

177Lu-octreotate for pancreatic NETs: van Vliet and colleagues describe outcomes of neoadjuvant treatment of pancreatic neuroendocrine tumors with peptide receptor radionuclide therapy in patients with borderline unresectable or oligometastatic disease.

Page 1647

Predicting 90Y microsphere outcomes: Ilhan and colleagues analyze the predictive value of 99mTc-MAA SPECT for 90Y-labeled resin microsphere radioembolization in primary and secondary liver malignancies by comparing uptake on pretherapeutic 99mTc-MAA SPECT with that on posttherapeutic 90Y SPECT.

Page 1654

18F-FEC PET/CT in radioembolization: Hartenbach and colleagues evaluate 18F-fluoroethylcholine PET/CT as a metabolic imaging technique for assessment of treatment response to 90Y radioembolization in patients with locally advanced hepatocellular carcinoma.

Page 1661

Texture features in PET: Yan and colleagues explore the effect of image reconstruction settings on more than 50 separate texture parameters in 18F-FDG PET images acquired on a PET/CT scanner incorporating point-spread function and time-of-flight technology.

Page 1667

PET/CT for breast cancer staging: Hogan and colleagues identify differences in 18F-FDG PET/CT systemic staging in women newly diagnosed with invasive lobular carcinoma and those with invasive ductal carcinoma.

Page 1674

PET/CT, early response, and breast cancer: Kostakoglu and colleagues determine whether an early change in 18F-FLT standardized uptake values using PET with CT can predict pathologic complete response of primary breast cancer to neoadjuvant chemotherapy.

Page 1681

Modulating NIS function in ATC cells: Singh and colleagues investigate the role of estrogen-related receptor γ in regulation of sodium iodide symporter function in anaplastic thyroid cancer cells using GSK5182, an inverse agonist of estrogen-related receptor γ.

Page 1690

68Ga-PSMA-617 in prostate cancer diagnosis: Afshar-Oromieh and colleagues detail the biodistribution of this prostate-specific membrane antigen–targeted PET radioligand in normal tissues and in prostate cancer and report on radiation exposure with the agent in PET imaging.

Page 1697

Innervation–MBF mismatch and 11C-HED: Harms and colleagues assess the rate of tracer influx from blood to myocardium on an 11C-HED PET scan as an index of myocardial blood flow, with potential for identifying areas of blood flow–innervation mismatch.

Page 1706

SPECT MPR in multivessel CAD: Ben Bouallègue and colleagues describe the feasibility of myocardial perfusion reserve estimation using a cadmium-zinc-telluride camera in a cohort of patients with multivessel coronary artery disease and correlate results with invasive angiographic data.

Page 1712

V/Q PET/CT in lung function: Le Roux and colleagues compare quantitative ventilation/perfusion PET/CT results and pulmonary function test data, with results that support the use of V/Q PET/CT in radiation therapy, preoperative planning, and pulmonary dysfunction assessment.

Page 1718

nAChR availability and nicotine metabolism: Dubroff and colleagues use 2-18F-FA PET to examine the relationship between nicotine metabolite ratio, a stable measure of hepatic nicotine metabolism, and nicotinic acetylcholine availability in smokers characterized as slow and normal metabolizers.

Page 1724

Cerebral 11C-laniquidar kinetics: Froklage and colleagues develop a pharmacokinetic model for quantification of uptake of this newly developed tracer of P-glycoprotein expression and assess its test–retest variability in healthy subjects.

Page 1730

18F-florbetapir PET quantification: Joshi and colleagues describe a semiautomated quantitative method for estimating 18F-florbetapir plaque binding using static 10-min PET images, evaluate the method’s accuracy, and compare derived standardized uptake value ratios with neuropathologic amyloid measures.

Page 1736

BAT/WAT discrimination with PET/MR: Franz and colleagues evaluate signal-fat-fraction analysis based on a 2-point-Dixon water–fat separation method in whole-body simultaneous PET/MR imaging for distinguishing brown adipose tissue from white adipose tissue.

Page 1742

90Y-DOTATOC in meningioma treatment: Gerster-Gilliéron and colleagues investigate whether somatostatin receptor–targeted radionuclide therapy with 90Y-DOTATOC may be an option in meningioma patients with recurrent or progressive meningiomas.

Page 1748

Molecular imaging in radiotherapy: Jeraj and colleagues provide an educational overview of molecular imaging applications in radiation therapy, with a focus on target definition, treatment response assessment, quantitative imaging requirements, potential limitations, and possibilities for future development.

Page 1752

211At RIT optimized mAb dose: Frost and colleagues report on optimization of the anti-CD45 monoclonal antibody protein dose for 211At radioimmunotherapy in hematopoietic cell transplantation, including tracer activity distribution and α-imaging–based small-scale dosimetry.

Page 1766

Enhancing SC therapy in brain injury: Zhang and colleagues use spatiotemporal PET to investigate metabolic changes after combined therapy with induced pluripotent stem cells, neuronal stem cells, and Chinese patent medicine in a rat model of cerebral ischemia–reperfusion injury.

Page 1774

PET and PTK7 expression: Jacobson and colleagues describe the development of a specific, selective, and high-affinity PET radioligand based on a single-stranded DNA aptamer to address challenges in noninvasively visualizing tumoral expression of protein tyrosine kinase-7.

Page 1780

Hyperpolarized 13C-pyruvate and 18F-FDG PET: Gutte and colleagues establish a practical workflow for tumor tissue characterization with simultaneous 18F-FDG PET and hyperpolarized 13C-pyruvate MR spectroscopy and test its feasibility in dogs with cancer.

Page 1786

Intraarterial microdosing and PET: Burt and colleagues describe 18F-FDG PET assessment of preclinical studies evaluating a novel drug development approach combining intraarterial drug delivery and microdosing.

Page 1793

Biodistribution of 131I-tositumomab: Wahl and colleagues investigate whether altered biodistribution of 131I-tositumomab can be identified using quantitative calculations of whole-body residence time alone for decision making about administration of therapeutic doses.

Page 1800

  • © 2015 by the Society of Nuclear Medicine and Molecular Imaging, Inc.
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 56 (11)
Journal of Nuclear Medicine
Vol. 56, Issue 11
November 1, 2015
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
This Month in JNM
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
This Month in JNM
Journal of Nuclear Medicine Nov 2015, 56 (11) 8A;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
This Month in JNM
Journal of Nuclear Medicine Nov 2015, 56 (11) 8A;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • A Phase II Study of 3′-Deoxy-3′-18F-Fluorothymidine PET in the Assessment of Early Response of Breast Cancer to Neoadjuvant Chemotherapy: Results from ACRIN 6688
  • Nanoparticles for Cardiovascular Imaging and Therapeutic Delivery, Part 2: Radiolabeled Probes
  • Observational Retrospective Study of Altered Biodistribution of Tositumomab and 131I-Tositumomab
  • A Semiautomated Method for Quantification of F 18 Florbetapir PET Images
  • Evaluating Treatment Response of Radioembolization in Intermediate-Stage Hepatocellular Carcinoma Patients Using 18F-Fluoroethylcholine PET/CT
  • Neoadjuvant Treatment of Nonfunctioning Pancreatic Neuroendocrine Tumors with [177Lu-DOTA0,Tyr3]Octreotate
  • Impact of Image Reconstruction Settings on Texture Features in 18F-FDG PET
  • Use of a Single 11C-Meta-Hydroxyephedrine Scan for Assessing Flow–Innervation Mismatches in Patients with Ischemic Cardiomyopathy
  • Myocardial Blood Flow and Innervation Measures from a Single Scan: An Appealing Concept but a Challenging Paradigm
  • The Theranostic PSMA Ligand PSMA-617 in the Diagnosis of Prostate Cancer by PET/CT: Biodistribution in Humans, Radiation Dosimetry, and First Evaluation of Tumor Lesions
  • Tumor Texture Analysis in PET: Where Do We Stand?
  • Quantification of 11C-Laniquidar Kinetics in the Brain
  • 18F-Labeled Single-Stranded DNA Aptamer for PET Imaging of Protein Tyrosine Kinase-7 Expression
  • Discrimination Between Brown and White Adipose Tissue Using a 2-Point Dixon Water–Fat Separation Method in Simultaneous PET/MRI
  • Spatiotemporal PET Imaging of Dynamic Metabolic Changes After Therapeutic Approaches of Induced Pluripotent Stem Cells, Neuronal Stem Cells, and a Chinese Patent Medicine in Stroke
  • α-Imaging Confirmed Efficient Targeting of CD45-Positive Cells After 211At-Radioimmunotherapy for Hematopoietic Cell Transplantation
  • Simultaneous Hyperpolarized 13C-Pyruvate MRI and 18F-FDG PET (HyperPET) in 10 Dogs with Cancer
  • Inverse Agonist of Estrogen-Related Receptor γ Enhances Sodium Iodide Symporter Function Through Mitogen-Activated Protein Kinase Signaling in Anaplastic Thyroid Cancer Cells
  • 90Y-DOTATOC as a Therapeutic Option for Complex Recurrent or Progressive Meningiomas
  • SPECT Myocardial Perfusion Reserve in Patients with Multivessel Coronary Disease: Correlation with Angiographic Findings and Invasive Fractional Flow Reserve Measurements
  • Molecular Imaging to Plan Radiotherapy and Evaluate Its Efficacy
  • Intraarterial Microdosing: A Novel Drug Development Approach, Proof-of-Concept PET Study in Rats
  • Correlation of 68Ga Ventilation–Perfusion PET/CT with Pulmonary Function Test Indices for Assessing Lung Function
  • Comparison of 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma
  • Decreased Nicotinic Receptor Availability in Smokers with Slow Rates of Nicotine Metabolism
  • Predictive Value of 99mTc-MAA SPECT for 90Y-Labeled Resin Microsphere Distribution in Radioembolization of Primary and Secondary Hepatic Tumors
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • This Month in JNM
  • This Month in JNM
  • This Month in JNM
Show more This Month in JNM

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire